Regeneron Pharmaceuticals Inc. stock outperforms market on strong trading day

This post was originally published on this site

Shares of Regeneron Pharmaceuticals Inc. REGN, +0.68% inched 0.68% higher to $650.49 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX, -0.77% falling 0.77% to 4,458.58 and Dow Jones Industrial Average DJIA, -0.78% falling 0.78% to 34,607.72. Regeneron Pharmaceuticals Inc. closed $36.13 below its 52-week high ($686.62), which the company achieved on September 3rd.

The stock outperformed some of its competitors Friday, as Johnson & Johnson JNJ, -0.65% fell 0.65% to $166.97, Novartis AG ADR NVS, -1.23% fell 1.23% to $85.43, and Amgen Inc. AMGN, -0.85% fell 0.85% to $213.75. Trading volume (741,688) eclipsed its 50-day average volume of 737,834.

Related Posts